Skip to main content

Medicinova Inc (MNOV)

Sector
Healthcare
Industry
Biotechnology
Last price
$1.34
As of

Kresmion compiles this page from MNOV's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

MEDICINOVA INC (MNOV): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q3 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-16.

As of . Source: SEC EDGAR filings for MNOV. Method and limitations.

COMPANY DOSSIER

See the full MNOV dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for MNOV on one page. Preview it with sample data, then open it live with a free account.

Preview the MNOV dossier

Active events for MNOV

  • mediumEarnings above estimates

    Q3-2026: Beat consensus by 6.0%, EPS $-0.06 vs $-0.0638 estimate

  • mediumEarnings above estimates

    Q2-2026: Beat consensus by 22.6%, EPS $-0.05 vs $-0.0646 estimate

  • high13F: large reduction

    TWO SIGMA INVESTMENTS, LP cut 55% of MNOV (2026Q2)

  • mediumEarnings above estimates

    Q2-2025: Beat consensus by 27.8% - EPS $-0.07 vs $-0.0969 estimate

  • mediumEarnings above estimates

    Q3-2025: Beat consensus by 41.2% - EPS $-0.06 vs $-0.102 estimate

FREE, NO ACCOUNT

Every event on MNOV, as it fires

You are seeing 5 of 9 events recorded on MNOV since 2026-05-24.

The five above landed across 4 days. The other 4 were recorded on 1 other days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

MNOV positions held by the managers we follow (2026Q3)

What the managers we follow bought and sold in Q2 2026

Manager / securityMarket value% of reported value
RENAISSANCE TECHNOLOGIES LLC FundCUSIP 58468P206 · 2026Q3$376K0.00%

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, MNOV

More data on MNOV

MNOV against its peers

MNOV's operating margin of -3242.5% ranks in the 14th percentile of 10 Biotechnology sub-industry peers, fiscal periods ending between 2025-03-31 and 2026-04-30.

MetricMNOVPeer medianPercentilen
Revenue FY409657 USD7.9M USD1311
Gross marginn/a66.9%n/a5
Operating margin-3242.5%-251.6%1410
Net margin-2928.8%-267.1%2111
Return on equity-28.9%-81.7%9218
1 year-6.3%-48.2%8021

Peers (23): GOSS, NRXS, CRBP, COYA, NTRB, ACRV, CSBR, CING, SMNR, MAIA, ATRA, MIST, TENX, KZIA, RANI, CRDF, FBIO, OKYO, CGTX, XBIT, TNYA, HRTX, NMRA. Left out: CNXU (no annual filing), TLSA (period gap). Fiscal periods ending between 2025-03-31 and 2026-04-30. Every figure is one full fiscal year read from one annual filing (MNOV: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in MNOV on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on MNOV in the last 180 days.

Upstream: SEC EDGAR filings for MNOV

Kresmion, "MEDICINOVA INC (MNOV) institutional holdings and SEC filings", data as of 2026-11-17, https://kresmion.com/research/MNOV. Upstream data: SEC EDGAR filings for MNOV.

Link to this data (HTML):

<a href="https://kresmion.com/research/MNOV">MEDICINOVA INC (MNOV) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow MNOV on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to MNOV for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the MNOV dossier
Share

The MNOV intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.